GVR Report cover Cerebral Spinal Fluid Management Market Size, Share & Trends Report

Cerebral Spinal Fluid Management Market Size, Share & Trends Analysis Report By Product (CSF Shunts, CSF Drainage), By Region (North America, Europe, Asia Pacific, Row), And Segment Forecasts, 2012 - 2022

  • Report ID: GVR-1-68038-373-7
  • Number of Pages: 64
  • Format: Electronic (PDF)
  • Historical Range: 2012 - 2016
  • Industry: Healthcare

Industry Insights

The global cerebral spinal fluid management market size was valued at USD 879.1 million in 2014 and is projected to witness lucrative growth year-on-year growth. The unique nature of cerebrospinal fluid dynamics in each patient has challenged neurologists, neurosurgeons, and medical device developers. This has led to increasing demand for advanced cerebral spinal fluid (CSF) management devices.

Rapid advancements in ongoing research projects related to brain barriers and brain fluids are anticipated to impact the market growth to a large extent. These research projects are mainly aimed at the management of hydrocephalus and other cerebrospinal fluid-associated disorders.

Europe CSF management market share, by CSF drainage product, 2012 - 2022

Europe CSF management market

These products have attracted a significant amount of attention owing to the potential prospects of the application in the treatment of hydrocephalus and other brain-associated disorders. This is primarily attributable to the lack of proper treatment for such diseases, which prompts the neurologist to invest in the development of these products.

According to Hydrocephalus Association, nearly 700,000 older Americans are estimated to live with normal pressure hydrocephalus. Moreover, it is observed that one to two out of every 1,000 babies are born with this condition. The presence of such a large population base suffering from the disease is expected to drive the demand for these products and platforms.

Furthermore, conferences and workshops on basic science research and its translation into diagnosis and treatment of cerebrospinal fluid disorders are expected to propagate the growth in this segment of neurology devices. These conferences are intended to increase awareness amongst neurosurgeons, nurse practitioners, and physicians about current treatment options for such disorders and for the advancements in these options.

Product Insights

CSF shunts and drainage systems are used for the purpose of cerebrospinal fluid management. Shunts are found to be useful for the diversion of CSF in a controlled manner away from the central nervous system (CNS) fluid compartments. It provides an alternative pathway for the fluid flow

Being the most conventional method, shunts captured the larger cerebrospinal fluid management market share in terms of revenue generation. These shunts are considered a common and primary treatment/therapy for hydrocephalus management. Moreover, technological advancements in these devices to combat the issues pertaining to biocompatibility, infection, and fouling are expected to contribute to the future growth of this segment.

Drainage devices are expected to emerge as the fastest-growing segment over the forecast period. This is due to their wide spectrum application in monitoring several CSF-related conditions. In addition, research in this segment to address the limitations associated with existing devices is expected to augment the progress of this segment. For instance, recently, BeckerSmith Medical, Inc. introduced the first automated cerebral spinal fluid drain monitoring system that facilitates the reduction of ICU workload and length of stay.

Global CSF management market, by region, 2014 (USD Million)

>Global CSF management market


The development of platforms by identification and development of proprietary technologies for solving the unmet clinical needs and treating the chronic nervous ailments such as Subarachnoid hemorrhage and hydrocephalus is projected to fuel growth in this sector over the forecast period. Ongoing research for deriving and developing the application of the CSF management platforms in the treatment of neurotoxic diseases is attributive to driving industrial growth significantly.

The introduction and implementation of such platforms are anticipated to facilitate less utilization of hospital resources by the reduction in length of stay, improving clinical functional outcomes, and an overall reduced healthcare economic burden thus accelerating the adoption rate.

Regional Insights

The North American market is expected to contribute the highest revenue over the forecast period as a result of increasing the growth of the geriatric population suffering from nervous disorders coupled with rising approvals by the U.S. FDA for new products. As of 2014, it held more than 39.0% of the global cerebral spinal fluid management market share.

The Asia Pacific regional market is anticipated to witness lucrative growth over the forecast period owing to increasing awareness about neurological diseases and related treatment options in the region coupled with a rising incidence of stroke disease. Increasing penetration of the Original Equipment Manufacturers in the developing economies to tap the potential market is anticipated to boost growth in this region.

Cerebral Spinal Fluid Management Market Share Insights

Key players contributing to the cerebrospinal fluid management market space include Magstim, B. Braun Melsungen AG; Johnson & Johnson Services, Inc; Integra LifeSciences Corporation; Spiegelberg GmbH & Co. KG; Medtronic, Inc.; Sophysa; Beckersmith Medical, Inc; Elekta AB; and Phoenix Biomedical Corp.

The companies are undertaking different strategic initiatives including mergers, acquisitions, regional expansion, new product development, and strategic collaboration in order to sustain their position in the market. For instance, in 2015, Codman Neuro (operating unit of Johnson & Johnson Services, Inc.) introduced a novel MRI-resistant programmable valve with eight different pressure settings that offer constant intra-ventricular pressure and CSF drainage for hydrocephalus treatment.

Report Scope 



Base year for estimation


Actual estimates/Historical data

2012 - 2016

Forecast period

2017 - 2022

Market representation

Revenue in USD Million and CAGR from 2015 to 2022

Regional scope

North America, Europe, Asia Pacific, and ROW.

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

15% free customization scope (equivalent to 5 analyst working days)

If you are looking for specific or additional market information, which is not currently within the scope of the report, we will provide it to you as a part of the customization

Segments Covered in the Report

This report forecasts revenue growth at global & regional and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2012 to 2022. For the purpose of this study, Grand View Research has segmented the global cerebral spinal fluid management market on the basis of product and region:

  • Product Outlook (Revenue, USD Million; 2012 - 2022)

    • CSF shunts

    • CSF drainage

  • Regional Outlook (Revenue, USD Million; 2012 - 2022)

    • North America

    • Europe

    • Asia Pacific

    • RoW

gvr icn


gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.